A very clear opportunity exists today to capitalize on the growth of Generic Pharmaceuticals, Functional food ingredients, Life Science Innovation, and Biotech. We understand how to bring quality health and wellness to local markets.
Our mandate is as follows:
- In-Licensing of Pharmaceuticals to Emerging markets
- Seek high value orphan drugs, generics, OTC, hospitals and firms which are Best-In-Class
- Find arbitrage opportunities. These opportunities could be in the form of distressed assets, supply chain
- Negotiate and discuss with leading partners in select markets in order to capitalize on this opportunity for increased valuations on an exit strategy